Madrs Depression Score Calculator

Score depression severity using the Montgomery-Asberg Depression Rating Scale. Enter values for instant results with step-by-step formulas.

Share this calculator

X Facebook LinkedIn

Formula

MADRS Total = Sum of 10 items (each scored 0-6, range 0-60)

Each of the 10 items is rated from 0 (no abnormality) to 6 (severe). Odd-number scores represent intermediate severity levels. Total score categories: 0-6 Normal, 7-19 Mild, 20-34 Moderate, 35-60 Severe depression.

Worked Examples

Example 1: Mild Depressive Episode Assessment

Problem: A 34-year-old female presents with reported sadness (score 2), inner tension (score 2), reduced sleep (score 2), concentration difficulties (score 1), lassitude (score 1), and pessimistic thoughts (score 1). All other items score 0.

Solution: MADRS = 0 + 2 + 2 + 2 + 0 + 1 + 1 + 0 + 1 + 0 = 9\nSeverity: Mild Depression (7-19 range)\nCore symptoms: 2 (sadness items)\nVegetative symptoms: 3 (sleep + appetite + lassitude)\nCognitive symptoms: 2 (concentration + inability to feel + pessimism)\nSuicidal risk: 0 (none)

Result: MADRS Total: 9 (Mild Depression) | Psychotherapy and reassessment recommended

Example 2: Moderate-to-Severe Depression with Suicidal Ideation

Problem: A 52-year-old male presents with apparent sadness (4), reported sadness (4), inner tension (3), reduced sleep (4), reduced appetite (3), concentration difficulties (3), lassitude (4), inability to feel (3), pessimistic thoughts (4), suicidal thoughts (3).

Solution: MADRS = 4 + 4 + 3 + 4 + 3 + 3 + 4 + 3 + 4 + 3 = 35\nSeverity: Severe Depression (35-60 range)\nCore symptoms: 8 (sadness items)\nVegetative symptoms: 11 (sleep + appetite + lassitude)\nCognitive symptoms: 10 (concentration + feeling + pessimism)\nSuicidal risk: 3 (ELEVATED - immediate intervention needed)

Result: MADRS Total: 35 (Severe) | Suicidal risk elevated | Urgent psychiatric intervention required

Frequently Asked Questions

What is the Montgomery-Asberg Depression Rating Scale (MADRS)?

The MADRS is a clinician-administered diagnostic questionnaire used to measure the severity of depressive episodes in patients with mood disorders. Developed by Stuart Montgomery and Marie Asberg in 1979, it consists of 10 items that assess the core symptoms of depression including apparent sadness, reported sadness, inner tension, sleep disturbance, appetite changes, concentration difficulties, lassitude, inability to feel, pessimistic thoughts, and suicidal thoughts. Each item is scored from 0 to 6, yielding a total score range of 0 to 60. The MADRS is particularly sensitive to treatment-induced changes and is therefore frequently used in clinical trials evaluating antidepressant efficacy.

How do MADRS severity categories guide treatment decisions?

MADRS scores are typically categorized into four severity levels that inform clinical management. Scores of 0 to 6 indicate no clinically significant depression and typically require no active treatment beyond routine follow-up. Scores of 7 to 19 represent mild depression where psychotherapy alone or watchful waiting with lifestyle modifications may be appropriate. Scores of 20 to 34 indicate moderate depression where antidepressant medication combined with psychotherapy is generally recommended as first-line treatment. Scores of 35 to 60 represent severe depression requiring urgent psychiatric intervention, possible hospitalization, and aggressive pharmacological management including consideration of electroconvulsive therapy in treatment-resistant cases.

How does the MADRS compare to the Hamilton Depression Rating Scale?

Both the MADRS and the Hamilton Depression Rating Scale (HAM-D or HDRS) are widely used clinician-rated instruments for assessing depression severity, but they differ in several important ways. The MADRS has fewer items (10 versus 17 or 21 for HAM-D) making it quicker to administer, typically taking 15-20 minutes compared to 20-30 minutes for the HAM-D. The MADRS places greater emphasis on core psychological symptoms of depression and is considered more sensitive to changes during antidepressant treatment, making it preferred in clinical trials. The HAM-D places more weight on somatic and anxiety symptoms, which can sometimes inflate scores in patients with comorbid medical conditions. Research suggests the MADRS has better inter-rater reliability and discriminant validity.

Who should administer the MADRS assessment?

The MADRS was designed to be administered by trained clinicians including psychiatrists, psychologists, psychiatric nurses, and other mental health professionals who have received specific training in its use. The clinician conducts a semi-structured interview and rates each item based on clinical judgment, considering both patient reports and observed behavior during the interview. While self-report versions (MADRS-S) have been developed and validated, the standard clinician-administered version provides more reliable and nuanced assessments. Training typically involves reviewing the scoring manual, observing experienced raters, and conducting practice interviews with reliability checks. Inter-rater reliability studies show that trained clinicians achieve high agreement on MADRS scoring.

How frequently should the MADRS be administered during treatment?

The frequency of MADRS assessment depends on the clinical context and treatment phase. During the acute phase of antidepressant treatment, assessments every 1 to 2 weeks are recommended to monitor early response and detect adverse effects. A clinically meaningful response is typically defined as a 50 percent or greater reduction from baseline MADRS score. Remission is generally defined as a MADRS score of 10 or below. During maintenance therapy, monthly assessments for the first 6 months followed by quarterly assessments are common practice. In clinical trials, MADRS is often administered at baseline, then at weeks 1, 2, 4, 6, and 8. If a patient shows deterioration or develops suicidal ideation, more frequent assessment is warranted.

What role does the suicidal thoughts item play in the MADRS?

The suicidal thoughts item (Item 10) is perhaps the most clinically critical component of the MADRS and requires careful evaluation regardless of the total score. Even if the overall MADRS score falls in the mild range, a high score on this single item demands immediate clinical attention and safety planning. The item assesses a spectrum from passive thoughts about life not being worth living through active suicidal ideation with specific plans and preparations. A score of 4 or above on this item suggests significant suicidal risk requiring immediate intervention, including safety assessment, removal of means, increased supervision, and potential psychiatric hospitalization. Clinicians must always follow up on elevated suicidal ideation scores with a thorough risk assessment.